Demographic and clinical characteristics of study participants
| Patient characteristics (N = 117) . | n (%) . |
|---|---|
| Demographic characteristics | |
| Age, mean (SD), y | 11.5 (2.8) |
| Female sex | 64 (54.7) |
| Ethnicity | |
| Hispanic or Latino | 7* (6.0) |
| African American | 109 (93.2) |
| Clinical characteristics | |
| Sickle cell disease genotype | |
| Hgb SS/SB0 | 72 (61.5) |
| Hgb SC | 35 (29.9) |
| Other | 10 (8.5) |
| Currently taking hydroxyurea (yes)† | 74 (63.3) |
| Took pain medications at home in the prior week (yes) | 26 (23.2) |
| Child self-report of general health | |
| Poor/fair | 13 (11.1) |
| Good | 41 (35.0) |
| Very good | 39 (33.3) |
| Excellent | 24 (20.5) |
| Patient characteristics (N = 117) . | n (%) . |
|---|---|
| Demographic characteristics | |
| Age, mean (SD), y | 11.5 (2.8) |
| Female sex | 64 (54.7) |
| Ethnicity | |
| Hispanic or Latino | 7* (6.0) |
| African American | 109 (93.2) |
| Clinical characteristics | |
| Sickle cell disease genotype | |
| Hgb SS/SB0 | 72 (61.5) |
| Hgb SC | 35 (29.9) |
| Other | 10 (8.5) |
| Currently taking hydroxyurea (yes)† | 74 (63.3) |
| Took pain medications at home in the prior week (yes) | 26 (23.2) |
| Child self-report of general health | |
| Poor/fair | 13 (11.1) |
| Good | 41 (35.0) |
| Very good | 39 (33.3) |
| Excellent | 24 (20.5) |